Testing methods for MGMT promoter methylation
Neuro-Oncology: The Podcast
English - July 23, 2021 19:29 - 13 minutes - 12 MB - ★★★★★ - 9 ratingsMedicine Health & Fitness Science Life Sciences brain oncology tumors glioblastoma glioma lymphoma neurology neurooncology Homepage Download Apple Podcasts Google Podcasts Overcast Castro Pocket Casts RSS feed
Previous Episode: Temozolomide-induced hypermutation in IDH-mutant low-grade gliomas
Next Episode: Molecular signatures of glioma causation
Dr. Iyad Alnahhas interviews Dr. Kathreena Kurian about her and her team's recent manuscript entitled: "MGMT promoter methylation testing to predict overall survival in people with glioblastoma treated with temozolomide: a comprehensive meta-analysis based on a Cochrane Review", published online in Neuro-Oncology in April 2021.